FDA NDC Directory · JSON-LD · Markdown

ERYTHROMYCIN ETHYLSUCCINATE

NDC 52536-132 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameErythromycin Ethylsuccinate
Labeler / ManufacturerWilshire Pharmaceuticals
Marketing categoryNew Drug Application (innovator) · App NDA050207
Dosage form / routeSUSPENSION · ORAL
Active ingredientsERYTHROMYCIN ETHYLSUCCINATE (200 mg/5mL)
Marketing started20200824
Package count1

External sources

Source: openFDA. Public-domain (CC0).